Your browser doesn't support javascript.
loading
Effectiveness of a Multifaced Antibiotic Stewardship Program: A Pre-Post Study in Seven Italian ICUs.
Mandelli, Giulia; Dore, Francesca; Langer, Martin; Garbero, Elena; Alagna, Laura; Bianchin, Andrea; Ciceri, Rita; Di Paolo, Antonello; Giani, Tommaso; Giugni, Aimone; Gori, Andrea; Lefons, Ugo; Muscatello, Antonio; Olivieri, Carlo; Pan, Angelo; Pedeferri, Matteo; Rossi, Marianna; Rossolini, Gian Maria; Russo, Emanuele; Silengo, Daniela; Viaggi, Bruno; Bertolini, Guido; Finazzi, Stefano.
  • Mandelli G; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milano, Italy.
  • Dore F; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milano, Italy.
  • Langer M; Associazione GiViTI-Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva, 24020 Ranica, Italy.
  • Garbero E; Associazione GiViTI-Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva, 24020 Ranica, Italy.
  • Alagna L; Emergency-Ong, 20128 Milano, Italy.
  • Bianchin A; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milano, Italy.
  • Ciceri R; Associazione GiViTI-Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva, 24020 Ranica, Italy.
  • Di Paolo A; Infectious Diseases Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Giani T; Anesthesia and Intensive Care, Ospedale Civile San Valentino di Montebelluna, 31044 Montebelluna, Italy.
  • Giugni A; Associazione GiViTI-Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva, 24020 Ranica, Italy.
  • Gori A; Anesthesia and Intensive Care, Ospedale Alessandro Manzoni di Lecco, 23900 Lecco, Italy.
  • Lefons U; Department of Clinical and Experimental Medicine, Università di Pisa, 56126 Pisa, Italy.
  • Muscatello A; Department of Experimental and Clinical Medicine, Università di Firenze, 50134 Firenze, Italy.
  • Olivieri C; Clinical Microbiology and Virology Unit, Azienda Ospedaliero Universitaria Careggi, 50134 Firenze, Italy.
  • Pan A; Associazione GiViTI-Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva, 24020 Ranica, Italy.
  • Pedeferri M; Department of Intensive Care and Emergency Medical Services, Ospedale Maggiore, 40133 Bologna, Italy.
  • Rossi M; Infectious Diseases Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Rossolini GM; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, 20122 Milan, Italy.
  • Russo E; Centre for Multidisciplinary Research in Health Science (MACH), Università degli Studi di Milano, 20122 Milan, Italy.
  • Silengo D; Anesthesia and Intensive Care, Ospedale Alta Val d'Elsa di Poggibonsi, 53036 Poggibonsi, Italy.
  • Viaggi B; Infectious Diseases Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Bertolini G; Associazione GiViTI-Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva, 24020 Ranica, Italy.
  • Finazzi S; Anesthesia and Intensive Care, Ospedale Sant'Andrea, ASL VC Vercelli, 13100 Vercelli, Italy.
J Clin Med ; 11(15)2022 Jul 28.
Article en En | MEDLINE | ID: mdl-35956026
Multidrug resistance has become a serious threat for health, particularly in hospital-acquired infections. To improve patients' safety and outcomes while maintaining the efficacy of antimicrobials, complex interventions are needed involving infection control and appropriate pharmacological treatments in antibiotic stewardship programs. We conducted a multicenter pre-post study to assess the impact of a stewardship program in seven Italian intensive care units (ICUs). Each ICU was visited by a multidisciplinary team involving clinicians, microbiologists, pharmacologists, infectious disease specialists, and data scientists. Interventions were targeted according to the characteristics of each unit. The effect of the program was measured with a panel of indicators computed with data from the MargheritaTre electronic health record. The median duration of empirical therapy decreased from 5.6 to 4.6 days and the use of quinolones dropped from 15.3% to 6%, both p < 0.001. The proportion of multi-drug-resistant bacteria (MDR) in ICU-acquired infections fell from 57.7% to 48.8%. ICU mortality and length of stay remained unchanged, indicating that reducing antibiotic administration did not harm patients' safety. This study shows that our stewardship program successfully improved the management of infections. This suggests that policy makers should tackle multidrug resistance with a multidisciplinary approach based on continuous monitoring and personalised interventions.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Evaluation_studies Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Evaluation_studies Idioma: En Año: 2022 Tipo del documento: Article